Cambium Bio Ltd Capital Reinvestment Ratio
Cambium Bio Ltd capital reinvestment ratio. Cambium Bio Ltd (CMB) has a Capital Reinvestment Ratio of 0.02x as of December 2023, meaning it reinvests 0% of its operating cash flow (AU$148.25K) in capital expenditures (AU$2.27K). Check Cambium Bio Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cambium Bio Ltd (1999–2021)
Capital reinvestment ratio of Cambium Bio Ltd from 1999 to 2021. This chart tracks Cambium Bio Ltd's Capital Reinvestment Ratio across 6 annual periods. Also explore CMB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Cambium Bio Ltd Capital Reinvestment Ratio by Year (1999–2021)
Cambium Bio Ltd capital reinvestment ratio by year from 1999 to 2021. For the full cash flow conversion analysis, see cash efficiency ratio of Cambium Bio Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | AU$2.42 Million | AU$7.78K | ▼ -92.3% |
| 2017 | 0.04x | AU$3.59 Million | AU$149.95K | ▼ -96.2% |
| 2002 | 1.11x | AU$5.43 Million | AU$6.01 Million | ▲ +107.3% |
| 2001 | 0.53x | AU$38.20 Million | AU$20.40 Million | ▲ +115.7% |
| 2000 | 0.25x | AU$48.26 Million | AU$11.95 Million | ▼ -54.9% |
| 1999 | 0.55x | AU$33.43 Million | AU$18.35 Million | — |